UroGen Pharma Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
UroGen Pharma Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • UroGen Pharma Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 36.8M shares, a 56.9% increase year-over-year.
  • UroGen Pharma Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 28.8M shares, a 26.4% increase from 2022.
  • UroGen Pharma Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 22.8M shares, a 2.06% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 36.8M +13.4M +56.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 33.4M +10.1M +43.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 28.8M +6.03M +26.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 32.3M +9.5M +41.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 23.5M +758K +3.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 23.3M +648K +2.87% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 22.8M +459K +2.06% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 22.8M +418K +1.87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 22.7M +372K +1.67% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 22.6M +389K +1.75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 22.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 22.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 22.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 22.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.